DPM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.326440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.238000E-01
Normal-vs-Stage2
6.542200E-02
Normal-vs-Stage3
4.260800E-01
Normal-vs-Stage4
3.753800E-01
Stage1-vs-Stage2
1.399420E-01
Stage1-vs-Stage3
8.630400E-01
Stage1-vs-Stage4
1.204020E-01
Stage2-vs-Stage3
2.923400E-01
Stage2-vs-Stage4
6.477600E-01
Stage3-vs-Stage4
2.097600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.160750E-01
Normal-vs-AfricanAmerican
7.144400E-01
Normal-vs-Asian
8.308600E-01
Caucasian-vs-AfricanAmerican
9.361400E-01
Caucasian-vs-Asian
4.519400E-01
AfricanAmerican-vs-Asian
6.378400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.711190E-01
Normal-vs-Female
2.159200E-01
Male-vs-Female
8.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.022400E-01
Normal-vs-Age(41-60Yrs)
1.510390E-02
Normal-vs-Age(61-80Yrs)
5.339800E-01
Normal-vs-Age(81-100Yrs)
5.743000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.390840E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.286200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.269600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.549800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.417800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.225600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.911000E-01
Normal-vs-Daily Drinker
3.816000E-01
Normal-vs-Weekly Drinker
7.642800E-01
Normal-vs-Occasional Drinker
4.935700E-02
Normal-vs-Social Drinker
7.071600E-01
Non Drinker-vs-Daily Drinker
3.501400E-01
Non Drinker-vs-Weekly Drinker
6.565600E-01
Non Drinker-vs-Occasional Drinker
5.625900E-02
Non Drinker-vs-Social Drinker
9.130600E-01
Daily Drinker-vs-Weekly Drinker
7.573000E-01
Daily Drinker-vs-Occasional Drinker
4.132000E-01
Daily Drinker-vs-Social Drinker
3.766000E-01
Weekly Drinker-vs-Occasional Drinker
3.006800E-01
Weekly Drinker-vs-Social Drinker
6.341800E-01
Occasional Drinker-vs-Social Drinker
7.030000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.957000E-01
Normal-vs-Grade 2
8.813800E-01
Normal-vs-Grade 3
9.477200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.734040E-02
Grade 1-vs-Grade 3
1.837680E-03
Grade 1-vs-Grade 4
7.957000E-01
Grade 2-vs-Grade 3
5.870400E-02
Grade 2-vs-Grade 4
8.813800E-01
Grade 3-vs-Grade 4
9.477200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.518000E-01
Normal-vs-NonDiabetic
1.693990E-01
Diabetic-vs-NonDiabetic
2.397200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.778600E-01
Normal-vs-NoPancreatitis
2.542400E-01
Pancreatitis-vs-NoPancreatitis
5.121800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.036800E-01
Normal-vs-N1
9.626400E-02
N0-vs-N1
5.441000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.162810E-03
Normal-vs-TP53-NonMutant
4.599400E-01
TP53-Mutant-vs-TP53-NonMutant
1.2502999999775E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
